About Us
Contact Us
Regulatory
Community
Site Map
Links
Stock Price
Glossary
Investor Relations
Media Gateway
Businesses
Governance
Uranium 101
Careers
Company Profile Why Invest? Events Calendar Management Views Financial Reporting Shareholder Information
Q3
Q2
Q1
Down Arrow
Contact IR
 
TSX:  $16.77 (-0.45)
NYSE:  $13.04 (-0.57)
  15 minute delay
Uranium Price
Print Page
Print Page

Balance Sheet

Consolidated Balance Sheets
(Unaudited)
(In Thousands)

    As At  
   
 
    March 31/00 December 31/99 March 31/99  

 
Assets              
Current assets              
  Cash $57,281   $45,469   $48,890    
  Accounts receivable 95,706   138,691   94,415    
  Inventories 374,918   356,828   350,975    
  Supplies and prepaid expenses 43,318   47,695   51,749    

 
    571,223   588,683   546,029    
                 
  Property, plant and equipment 2,160,522   2,135,843   2,304,031    
  Long-term receivables, investments and other 187,497   175,736   203,549    
  Inventories 40,121   63,881   183,089    

 
    2,388,140   2,375,460   2,690,669    

 
Total assets $2,959,363   $2,964,143   $3,236,698    

 
                 
Liabilities and Shareholders' Equity              
Current liabilities              
  Short-term debt $      -        $      -        $32,651    
  Accounts payable and accrued liabilities 74,458   105,873   92,558    
  Dividends payable 7,080   7,160   7,209    
  Current portion of long-term debt 30,430   30,241   28,231    
  Current portion of other liabilities 4,490   5,568   5,432    
  Deferred income taxes 30,597   32,549   29,794    

 
    147,055   181,391   195,875    
                 
  Long-term debt 354,877   328,963   574,938    
  Provision for reclamation 105,016   103,411   107,692    
  Other liabilities 18,818   15,618   13,511    
  Deferred income taxes 419,222   412,417   442,449    

 
    897,933   860,409   1,138,590    
                 
Shareholders' equity              
  Preferred securities 177,563   176,248   184,373    
  Share capital 676,231   683,787   688,534    
  Contributed surplus 485,633   490,771   496,745    
  Retained earnings 554,465   552,154   510,972    
  Cumulative translation account 20,483   19,383   21,609    

 
    1,914,375   1,922,343   1,902,233    

 
Total liabilities and shareholders' equity $2,959,363   $2,964,143   $3,236,698    

 
See accompanying notes to consolidated financial statements